NASDAQ:WGRX Wellgistics Health (WGRX) Stock Price, News & Analysis $3.98 +0.82 (+25.92%) As of 01:11 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Wellgistics Health Stock (NASDAQ:WGRX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Wellgistics Health alerts:Sign Up Key Stats Today's Range$3.42▼$4.1850-Day Range$3.16▼$8.7052-Week Range$3.04▼$128.00Volume9.23 million shsAverage Volume469,425 shsMarket Capitalization$9.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. In January 2023 and May 2023, Wellgistics Health entered into separate definitive agreements with the owners of Wood Sage and Wellgistics LLC, respectively, whereby Wellgistics Health would acquire all of the respective outstanding membership interests of Wood Sage and Wellgistics LLC. In June 2024, Wellgistics Health and Wood Sage entered into an amended and revised definitive agreement and closed on the Wood Sage Acquisition, thereby making Wood Sage a wholly owned subsidiary of Wellgistics Health. In connection with the Wood Sage Acquisition, Wellgistics Health acquired Wood Sage’s two operating subsidiaries, APS—a pharmaceutical technology hub—and CSP—a retail community specialty pharmacy. On August 30, 2024, Wellgistics Health closed on the Wellgistics Acquisition, thereby making Wellgistics LLC—a company focused on wholesale operations including the distribution and fulfillment of certain pharmaceutical medications to a network of independent pharmacies meant to improve market access to and patient outcomes regarding the medications—a wholly owned subsidiary of Wellgistics Health. As such, Wellgistics Health currently exists as a holding company with Wood Sage as a directly held intermediate holding company subsidiary, APS and CSP as indirect operating subsidiaries, and Wellgistics LLC as a direct operating subsidiary. On October 4, 2024, the Company changed its corporate name to “Wellgistics Health, Inc.” by filing a duly authorized Certificate of Amendment to its Certificate of Incorporation. Despite that Wellgistics Health only recently closed the Wood Sage Acquisition and the Wellgistics Acquisition during 2024, the three companies have shared common office space, comarketed solutions to the marketplace, and leveraged financial and back-office support prior to June 2024. As such, Wellgistics Health’s management believes that its close business relationships have and will continue to limit the need for post-closing integration. The mailing address of our principal executive office is 3000 Bayport Drive, Suite 950 Tampa, FL. Read More Wellgistics Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks8th Percentile Overall ScoreWGRX MarketRank™: Wellgistics Health scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingWellgistics Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageWellgistics Health has only been the subject of 1 research reports in the past 90 days.Read more about Wellgistics Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Wellgistics Health is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Wellgistics Health is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.12% of the float of Wellgistics Health has been sold short.Short Interest Ratio / Days to CoverWellgistics Health has a short interest ratio ("days to cover") of 0.51, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Wellgistics Health has recently increased by 281.16%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWellgistics Health does not currently pay a dividend.Dividend GrowthWellgistics Health does not have a long track record of dividend growth. News and Social Media2.4 / 5News Sentiment-0.17 News SentimentWellgistics Health has a news sentiment score of -0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Wellgistics Health this week, compared to 2 articles on an average week.Search Interest8 people have searched for WGRX on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.MarketBeat Follows1 people have added Wellgistics Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Wellgistics Health insiders have not sold or bought any company stock.Percentage Held by Insiders27.01% of the stock of Wellgistics Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsWellgistics Health has minimal institutional ownership at this time.Read more about Wellgistics Health's insider trading history. Receive WGRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Wellgistics Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WGRX Stock News HeadlinesWellgistics Health Stock to Reverse Split on Tuesday, May 26th (NASDAQ:WGRX)May 22, 2026 | americanbankingnews.comCORRECTION FROM SOURCE: Wellgistics Health Releases Letter to Our ShareholdersMay 21, 2026 | usatoday.comTrump Issues Emergency Order That Supports Elon Musk's Next VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.May 28 at 1:00 AM | Altimetry (Ad)Wellgistics Health Announces Transformative AI Healthcare Partnership DealMay 21, 2026 | tipranks.comWellgistics Health announces 1-for-50 reverse stock split to regain Nasdaq complianceMay 21, 2026 | msn.comWellgistics Health, Inc.: Wellgistics Health Announces Reverse Stock SplitMay 20, 2026 | finanznachrichten.deWellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo HealthMay 20, 2026 | businesswire.comWellgistics Health, Inc.: Wellgistics Health Reports First Quarter 2026 Financials and Provides Business UpdateMay 19, 2026 | finanznachrichten.deSee More Headlines WGRX Stock Analysis - Frequently Asked Questions How have WGRX shares performed this year? Wellgistics Health's stock was trading at $20.00 at the beginning of 2026. Since then, WGRX shares have decreased by 80.8% and is now trading at $3.8360. How were Wellgistics Health's earnings last quarter? Wellgistics Health, Inc. (NASDAQ:WGRX) released its quarterly earnings results on Tuesday, May, 19th. The company reported ($3.50) earnings per share (EPS) for the quarter. The firm had revenue of $1.56 million for the quarter. Wellgistics Health had a negative trailing twelve-month return on equity of 1,617.25% and a negative net margin of 545.69%. When did Wellgistics Health's stock split? Wellgistics Health's stock reverse split before market open on Tuesday, May 26th 2026.The 1-50 reverse split was announced on Wednesday, May 20th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 25th 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Wellgistics Health IPO? Wellgistics Health (WGRX) raised $4 million in an initial public offering on Friday, February 21st 2025. The company issued 900,000 shares at a price of $4.50-$5.50 per share. Craft Capital and D. Boral Capital (ex-EF Hutton) acted as the underwriters for the IPO. How do I buy shares of Wellgistics Health? Shares of WGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/19/2026Today5/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1d) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 WGRX's financial health is in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryWholesale Current SymbolNASDAQ:WGRX CIK2030763 WebN/A Phone1-843-302-1785FaxN/AEmployees31Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$101.28 million Net Margins-545.69% Pretax Margin-545.69% Return on Equity-1,617.25% Return on Assets-145.69% Debt Debt-to-Equity Ratio1.86 Current Ratio0.09 Quick Ratio0.03 Sales & Book Value Annual Sales$23.34 million Price / Sales0.43 Cash FlowN/A Price / Cash FlowN/A Book Value($5.99) per share Price / Book-0.66Miscellaneous Outstanding Shares2,510,000Free Float1,834,000Market Cap$9.99 million OptionableN/A Beta-1.17 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:WGRX) was last updated on 5/28/2026 by MarketBeat.com Staff. From Our PartnersBNZI Breakout Watch: AI Growth Meets Turnaround Setup!Banzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...Huge Alerts | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThe math on the SpaceX IPO is brokenSpaceX is expected to go public at a $1.75 trillion valuation. For investors to see a 10x return, the company ...Weiss Ratings | SponsoredA 25,000% opportunityAngel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...The Oxford Club | SponsoredI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | SponsoredThis Tech Could Be Bigger Than Apple, Amazon, and Microsoft CombinedA breakthrough technology backed by Elon Musk, Sam Altman, and Nvidia CEO Jensen Huang may hold the answer to ...Altimetry | SponsoredThe AI Shakeout Is Coming — Most Investors Won’t SurviveEvery major tech shift follows the same pattern: hype, a brutal shakeout, then a handful of winners that take ...Prosperity Research | SponsoredSMX Could Be One of the Most Interesting Small Caps Right NowSMX (Security Matters) Public Limited is developing molecular-level markers embedded into plastics, fuels, met...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wellgistics Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wellgistics Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
